NEWS ROOM
11 px font size 12 px font size 14 px font size
Media Releases
Newsletters
Media Contact
APOLLO NEWSLETTER
Professor Paul
Zimmet AO
Head of
International Diabetes Institute, Melbourne
"The data that I have seen so far makes this one of the most forward looking and best prospects of an oral insulin"
Click here to see Paul Zimmet's view on Apollo's oral insulin
Bill Moss AM
Non-Executive Director and
Investor
"Apollo has a number of opportunities to grow into the future. Opportunities perhaps that are much greater than many other companies many times their size"
Click here to hear Bill Moss's view on investing in Apollo
Newsletter
January 2008
    Opening order of AUD$105,000 for Apollo's Ellipse Skin Science range
    Phase I trial of Apollo's Oradel® insulin tablet to begin in mid-2008
    Sales of Apollo's human proteins double in second half of 2007
November 2007
    Apollo launches into Myer with new skincare range
    Apollo's oral insulin – key studies completed for trial
    Oradel™ and Intradel™ engines: The "machines" that drive Apollo's product pipeline
October 2007
    Oral Insulin - US Research Confirms Apollo is on the Right Track
    Obesity, Diabetes & Vascular Disease - Apollo Protein a Global Hit
    Apollo Pushes Towards Oral Insulin Clinical Trial
September 2007
    Apollo Scientific Advisory Board member to head world’s largest stem cell research institute
    Apollo creates first commercial hcx™ version of key stem cell factor
    Advancing Apollo’s human proteins patent position in four key areas: inflammation, cancer, metabolism and regeneration/stem cells
    Cost of arthritis soars, according to new study
August 2007
    Apollo signs major supply agreement with US giant
    As arthritis costs soar, the need for therapies also skyrockets
    Apollo’s insulin tablet makes the news
July 2007
    Apollo’s trial success - needle-free drug delivery
    Apollo strengthens its focus on drug development and trials
    Apollo’s human expressed protein is in demand
June 2007
    Strengthening Apollo's global patent position - Transdermal delivery
    Professor Zimmet wins prestigious Novartis Award
    Apollo's human proteins boost stem cell research
    Global media attention for Apollo's stem cell proteins
May 2007
    Taking the sting out of injections: Apollo develops needle-free vaccine
    Strengthening Apollo’s global patent position
    Apollo BIO Conference Success
    Oral Insulin: Better Health for a Better Price
April 2007
    Apollo leads the way with revolutionary oral insulin delivery
    Apollo flies the flag for Australia at BIO in the US
    Breakthrough in blood research confirms Apollo is on the right track
    Arthritis is crippling the economy
March 2007
    Thumbs up from Scientific Advisory Panel
    Meet Scientific Advisory Panel members
    Insulin in a tablet
    Apollo on the ground in the US
February 2007
    Arthritis tablet looking good
    Oral insulin: clinical human trials, here we come...
    Cashed up and ready to go full steam ahead
    TNF (Tough Nasty Factor) – what is it and how does it work?
December 2006
    Apollo celebrates Christmas with OTC launch
    Apollo reports on successful year
    Human proteins do the talking
    The real cost of diabetes
November 2006
    Stem cell hope for chemotherapy patients: new report
    Apollo begins tests of arthritis drugs in tablet form
    Apollo big in Japan
    Diabetes care for everyone
October 2006
    Diabetes behind bulging hospital budgets: new report
    Apollo proteins used in AIDS prevention quest
    Apollo's needle-free psoriasis treatment more than skin-deep
    Apollo moisturiser gets thumbs up
September 2006
    Top diabetes authority applauds Apollo's oral insulin
    Bloody good news : Red Cross to switch to Apollo proteins
    Apollo's future looks bright as Board gathers Moss
    Apollo to enter over-the-counter arthritis market, calls for trial volunteers